Comparing Efficacy of Azithromycin and Probiotics for Treatment of Acne Vulgaris
NCT ID: NCT05629468
Last Updated: 2022-12-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
75 participants
INTERVENTIONAL
2021-10-15
2022-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Anti-microbial Role of Non-antibiotic Agents Against Cutibacterium Acnes in Patients With Acne Vulgaris
NCT06179056
Vitamin A and Azithromycin for Acne Vulgaris
NCT03090048
A Pilot Study to Evaluate the Effect of a Probiotic Mixture in Acne
NCT03878238
Clinical Trial to Evaluate the Effect of a Probiotic in Acne
NCT04570319
the Comparison Efficacy of Azithromycin With Doxycycline in the Treatment of Acne Vulgaris
NCT00419848
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Azithromycin and Topical
group A (n=25) received tab. azithromycin 250mg oral on alternate days and topical cream benzoyl peroxide 4% twice a day daily for a period of 3 months
Azithromycin
antibiotic
Benzoyl Peroxide 4 % Topical Cream
topical cream
Probiotics and Topical
group B (n=25) received Probiotic sachet oral once a day everyday and topical cream benzoyl peroxide 4% twice a day daily for a period of 3 months
Probiotic Formula
probiotics
Benzoyl Peroxide 4 % Topical Cream
topical cream
Azithromycin and Probiotics and Topical
combination group C (n=25) received tab. azithromycin 250mg oral on alternate days, Probiotic sachet oral once a day everyday and topical cream benzoyl peroxide 4% twice a day daily for a period of 3 months
Azithromycin
antibiotic
Probiotic Formula
probiotics
Benzoyl Peroxide 4 % Topical Cream
topical cream
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Azithromycin
antibiotic
Probiotic Formula
probiotics
Benzoyl Peroxide 4 % Topical Cream
topical cream
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged between 15 and 35 years
Exclusion Criteria
* Other oral treatment for acne
* Allergic to any drug being used in the study
* Pregnancy
* PCOs
* Any drug which can interact with azithromycin
15 Years
35 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pak Emirates Military Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mushayada Irshad
Prinicipal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Akbar W Syed, PhD
Role: STUDY_DIRECTOR
Riphah International University, Islamabad
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
PEMH
Rawalpindi, Punjab Province, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A/28/EC/337/2021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.